Research use only. Not for use in humans or animals. All products and information on this site are provided strictly for in-vitro laboratory research purposes. They are not for use in humans or animals, and are not drugs, foods, cosmetics, or medical devices.
Tirzepatide Peptide: A Research Overview
Tirzepatide is a synthetic peptide studied as a dual agonist — it engages both the GIP receptor and the GLP-1 receptor. That dual mechanism placed it between the single-receptor incretin peptides and the newer triple agonists, and made it a central subject of metabolic-signaling research. This overview covers what tirzepatide is, its molecular class, and how to source research-grade material.
Tirzepatide at a glance
| Property | Value |
|---|---|
| Name | Tirzepatide (research designation LY3298176) |
| Class | Synthetic dual GIP / GLP-1 receptor agonist |
| Type | Long-acting incretin-analog peptide with a fatty-acid moiety |
| Appearance | White lyophilized powder |
The incretin research ladder
Incretin research peptides are best understood by how many receptors they engage:
- Semaglutide — single agonist (GLP-1 receptor).
- Tirzepatide — dual agonist (GIP + GLP-1 receptors).
- Retatrutide — triple agonist (GIP + GLP-1 + glucagon receptors).
Tirzepatide's addition of GIP-receptor engagement to GLP-1 activity is the defining feature researchers study. It also carries a fatty-acid moiety that extends its half-life in laboratory systems.
What tirzepatide is studied for
In laboratory and preclinical research, tirzepatide is studied for:
- Dual incretin-receptor signaling — comparative pharmacology across GIP and GLP-1 receptors.
- Energy-metabolism models — metabolic-marker research in animal models.
- Receptor-binding studies — affinity and selectivity characterization in vitro.
Tirzepatide offered here is a research chemical for laboratory use only. Not for use in humans or animals.
Tirzepatide vs semaglutide vs retatrutide
For the two most common comparisons researchers make, see the dedicated overviews:
- Retatrutide vs tirzepatide → — dual vs triple agonist.
- Semaglutide research overview → — the single-agonist reference point.
How research-grade material is verified
Every batch from a credible US supplier should arrive with a third-party Certificate of Analysis (COA) for that exact lot. Peptide Technologies publishes a COA on every batch and ties it to a QR code on the vial. A complete COA reports:
- Identity — mass spectrometry (ESI-MS) confirming the observed mass matches the theoretical mass of the target sequence.
- Purity — reverse-phase HPLC, reported as percent peak area at a fixed wavelength (typically 220 nm). Research-grade material is ≥99% by area.
- Net content — gravimetric confirmation the vial holds the stated mass within tolerance.
- Endotoxin — LAL assay below research-grade thresholds.
If a vendor cannot show a lot-specific COA, you cannot verify what is in the vial. Browse the full COA library →
How to source research-grade material
For laboratory research, sourcing quality comes down to a few checks:
- Lot-specific COA from an accredited, independent laboratory — not a generic marketing PDF.
- HPLC purity ≥99% by peak area, with the chromatogram shown.
- US synthesis and finishing, so the chain of custody is documented end to end.
- Cold-chain shipping for lyophilized material, so the product arrives stable.
Peptide Technologies meets each of these and publishes a third-party COA for every lot. Browse the public COA library →
FAQ
What is tirzepatide?
Tirzepatide is a synthetic peptide studied as a dual agonist of the GIP and GLP-1 receptors, used in metabolic-signaling research.
How is tirzepatide different from semaglutide?
Semaglutide is a single GLP-1-receptor agonist. Tirzepatide adds GIP-receptor engagement, making it a dual agonist.
How is tirzepatide different from retatrutide?
Tirzepatide is a dual agonist (GIP + GLP-1). Retatrutide is a triple agonist that adds glucagon-receptor engagement.
How is tirzepatide verified?
Research-grade tirzepatide is verified by HPLC for purity, mass spectrometry for identity, and an LAL endotoxin assay, reported on a lot-specific third-party COA.
Is tirzepatide a research chemical?
Yes. Tirzepatide supplied by Peptide Technologies is a research chemical for laboratory use only. Not for use in humans or animals.